Disease phenotype and management of axial psoriatic arthritis in Japan compared with other regions, particularly other Asian countries: results of the ASAS-PerSpA study
Patients with axPsA in Japan showed relatively lower disease activity and function than those from different geographic regions, especially in other Asian countries with less frequent csDMARD use.
Authors
- Clementina López‐Medina (ORCID: https://orcid.org/0000-0002-2309-5837)
- Gautam A. Deshpande (ORCID: https://orcid.org/0000-0002-0293-8911)
- Chamaida Plasencia‐Rodríguez (ORCID: https://orcid.org/0000-0003-3503-9047)
- Kurisu Tada (ORCID: https://orcid.org/0000-0002-6450-1993)
- Mitsumasa Kishimoto (ORCID: https://orcid.org/0000-0002-4007-1589)
- Anna Moltó (ORCID: https://orcid.org/0000-0003-2246-1986)
- Daiki Kobayashi
- Naoto Tamura (ORCID: https://orcid.org/0000-0003-1729-2954)
- Diego Benavent (ORCID: https://orcid.org/0000-0001-9119-5330)
- Victoria Navarro‐Compán (ORCID: https://orcid.org/0000-0002-4527-852X)
- Masato Okada (ORCID: https://orcid.org/0000-0002-0357-0127)
- Haruki Sawada (ORCID: https://orcid.org/0000-0002-2458-5918)
- Maxime Dougados (ORCID: https://orcid.org/0000-0003-3009-6229)
Institutions
- Délégation Paris 5 (FR)
- University of Hawaii System (US)
- Inserm (FR)
- Kyorin University (JP)
- Université Paris Cité (FR)
- Hospital Universitario La Paz (ES)
- Bellvitge University Hospital (ES)
- Juntendo University (JP)
- St. Luke's International Hospital (JP)
- Sorbonne Paris Cité (FR)
- Hôpital Cochin (FR)
- Hospital Universitario Reina Sofía (ES)
- Tokyo Medical University Ibaraki Medical Center (JP)
- Cordoba University (US)
Publication Details
- Journal
- BMC Rheumatology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1186/s41927-025-00580-1
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer